# Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

> **NCT04253626** · PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 83 (actual)

## Conditions studied

- Pregnancy Related
- Anemia, Iron Deficiency

## Interventions

- **DRUG:** Ferumoxytol Injection [Feraheme]
- **DRUG:** Ferrous Sulfate

## Key facts

- **NCT ID:** NCT04253626
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-21
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2025-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04253626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04253626, "Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04253626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*